ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Evgen Pharma recruits over 100 patients into COVID-19 trial pharmatimes
February 19, 2021UK-based Evgen Pharma has announced that it has now recruited a total of 102 patients into a trial investigating its lead asset SFX-01 in COVID-19. -
Evgen scores full approval for COVID-19 trial launch pharmatimes
October 28, 2020Evgen Pharma has received full regulatory approval for its STAR trial, which will investigate the company’s lead asset to treat acute respiratory distress syndrome (ARDS) in patients with suspected COVID-19. -
Evgen's SFX-01 selected for COVID-19 trial pharmatimes
June 18, 2020Evgen Pharma's lead candidate SFX-01 has been selected for evaluation in a randomised Phase II/III trial, to be sponsored by the University of Dundee, which aims to investigate its potential as a treatment for COVID-19.
Pharma Sources Insight January 2025
